Merck (MRK) Current Deferred Tax Assets (2009 - 2023)

Merck (MRK) has 15 years of Current Deferred Tax Assets data on file, last reported at $6.6 billion in Q2 2023.

• Current Deferred Tax Assets for Q2 2023 came in at $6.6 billion, down 2.51% year-over-year; the trailing twelve-month figure through Jun 2023 was $6.6 billion (down 2.51% YoY), and the FY2022 annual result was $7.2 billion, up 2.6% from the prior year.
• Current Deferred Tax Assets declined to $6.6 billion in Q2 2023 per MRK's latest filing, from $6.7 billion in the prior quarter.
• Over five years, Current Deferred Tax Assets peaked at $7.2 billion in Q3 2022 and troughed at $3.2 billion in Q1 2019.
• A 5-year average of $5.6 billion and a median of $6.0 billion in 2021 frame the typical range for Current Deferred Tax Assets.
• The sharpest annual moves came in 2019 and 2021: Current Deferred Tax Assets slipped 21.38% in 2019, then soared 49.49% in 2021.
• A 5-year view of Current Deferred Tax Assets shows it stood at $4.3 billion in 2019, then advanced by 9.28% to $4.7 billion in 2020, then soared by 49.49% to $7.0 billion in 2021, then increased by 2.6% to $7.2 billion in 2022, then fell by 7.39% to $6.6 billion in 2023.
• Business Quant data shows MRK's Current Deferred Tax Assets at $6.6 billion in Q2 2023, $6.7 billion in Q1 2023, and $7.2 billion in Q4 2022.